Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems like acne, excessive hair growth, and oily skin are common in women with PCOS and can help with early diagnosis.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Women with PCOS have thicker parafoveal areas in their retinas, but their macular blood vessel density is normal.

Most women lack knowledge about androgens and their excess symptoms.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

A significant number of Nigerian women struggling with infertility have Polycystic Ovary Syndrome, with the exact percentage varying based on the diagnostic criteria used.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

Classical PCOS types A and B are most common and linked to higher health risks.

STK11 gene polymorphism does not predict metformin response in PCOS.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Diagnosing and treating PCOS in teenagers is difficult, and the focus is on lifestyle changes and medication to improve health and prevent future issues.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Some women with PCOS have rare genetic variants linked to the condition.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.